APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ligases Enzymes

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ligases Enzymes Market Outlook and Growth Opportunities 2026

24 December 2025206 pages

Choose your research edition.

Industry ResearchLigases Enzymes Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Ligases Enzymes Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Ligases Enzymes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ligases Enzymes Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Ligases Enzymes Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Ligases Enzymes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ligases Enzymes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ligases Enzymes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ligases Enzymes market include Agilent, BioRad, Illumina, Inc., New England Biolabs, Promega, QIAGEN, Roche, Takara and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ligases Enzymes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ligases Enzymes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ligases Enzymes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ligases Enzymes market size, projected growth trends, production technologies, key applications, and end-use industries.

Ligases Enzymes Segment by Company

Agilent

BioRad

Illumina, Inc.

New England Biolabs

Promega

QIAGEN

Roche

Takara

Thermo Fisher Scientific

Abclonal

Fapon Biotech Inc

Novoprotein

CWbio

Vazyme

TransGen Biotech

Yeasen

Ligases Enzymes Segment by Type

DNA Ligase

RNA Ligase

Ligases Enzymes Segment by Application

Pharmaceutical & Biotechnology Companies

Hospitals & Diagnostic Centers

Academic & Research Institutes

Others

Ligases Enzymes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ligases Enzymes status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ligases Enzymes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ligases Enzymes significant trends, drivers, influence factors in global and regions.

6. To analyze Ligases Enzymes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ligases Enzymes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ligases Enzymes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ligases Enzymes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ligases Enzymes market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ligases Enzymes industry.

Chapter 3: Detailed analysis of Ligases Enzymes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ligases Enzymes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ligases Enzymes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ligases Enzymes Industry Trends Table 2. Ligases Enzymes Industry Drivers Table 3. Ligases Enzymes Industry Opportunities and Challenges Table 4. Ligases Enzymes Industry Restraints Table 5. Global Ligases Enzymes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ligases Enzymes Revenue Share by Company (2021-2026) Table 7. Global Ligases Enzymes Sales Volume by Company (kg) & (2021-2026) Table 8. Global Ligases Enzymes Sales Volume Share by Company (2021-2026) Table 9. Global Ligases Enzymes Average Price (USD/g) of Company (2021-2026) Table 10. Global Ligases Enzymes Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ligases Enzymes Key Company Manufacturing Base & Headquarters Table 12. Global Ligases Enzymes Company, Product Type & Application Table 13. Global Ligases Enzymes Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ligases Enzymes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of DNA Ligase Table 18. Significant Companies of RNA Ligase Table 19. Global Ligases Enzymes Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Ligases Enzymes Sales Volume by Type (2021-2026) & (kg) Table 21. Global Ligases Enzymes Sales Volume by Type (2027-2032) & (kg) Table 22. Global Ligases Enzymes Sales Volume Share by Type (2021-2026) Table 23. Global Ligases Enzymes Sales Volume Share by Type (2027-2032) Table 24. Global Ligases Enzymes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ligases Enzymes Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ligases Enzymes Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ligases Enzymes Sales Value Share by Type (2021-2026) Table 28. Global Ligases Enzymes Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical & Biotechnology Companies Table 30. Significant Companies of Hospitals & Diagnostic Centers Table 31. Significant Companies of Academic & Research Institutes Table 32. Significant Companies of Others Table 33. Global Ligases Enzymes Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Ligases Enzymes Sales Volume by Application (2021-2026) & (kg) Table 35. Global Ligases Enzymes Sales Volume by Application (2027-2032) & (kg) Table 36. Global Ligases Enzymes Sales Volume Share by Application (2021-2026) Table 37. Global Ligases Enzymes Sales Volume Share by Application (2027-2032) Table 38. Global Ligases Enzymes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ligases Enzymes Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ligases Enzymes Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ligases Enzymes Sales Value Share by Application (2021-2026) Table 42. Global Ligases Enzymes Sales Value Share by Application (2027-2032) Table 43. Global Ligases Enzymes Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Ligases Enzymes Sales by Region (2021-2026) & (kg) Table 45. Global Ligases Enzymes Sales Market Share by Region (2021-2026) Table 46. Global Ligases Enzymes Sales by Region (2027-2032) & (kg) Table 47. Global Ligases Enzymes Sales Market Share by Region (2027-2032) Table 48. Global Ligases Enzymes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ligases Enzymes Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ligases Enzymes Sales Value Share by Region (2021-2026) Table 51. Global Ligases Enzymes Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ligases Enzymes Sales Value Share by Region (2027-2032) Table 53. Global Ligases Enzymes Market Average Price (USD/g) by Region (2021-2026) Table 54. Global Ligases Enzymes Market Average Price (USD/g) by Region (2027-2032) Table 55. Global Ligases Enzymes Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Ligases Enzymes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ligases Enzymes Sales by Country (2021-2026) & (kg) Table 58. Global Ligases Enzymes Sales Market Share by Country (2021-2026) Table 59. Global Ligases Enzymes Sales by Country (2027-2032) & (kg) Table 60. Global Ligases Enzymes Sales Market Share by Country (2027-2032) Table 61. Global Ligases Enzymes Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ligases Enzymes Sales Value Market Share by Country (2021-2026) Table 63. Global Ligases Enzymes Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ligases Enzymes Sales Value Market Share by Country (2027-2032) Table 65. Agilent Company Information Table 66. Agilent Business Overview Table 67. Agilent Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 68. Agilent Ligases Enzymes Product Portfolio Table 69. Agilent Recent Development Table 70. BioRad Company Information Table 71. BioRad Business Overview Table 72. BioRad Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 73. BioRad Ligases Enzymes Product Portfolio Table 74. BioRad Recent Development Table 75. Illumina, Inc. Company Information Table 76. Illumina, Inc. Business Overview Table 77. Illumina, Inc. Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 78. Illumina, Inc. Ligases Enzymes Product Portfolio Table 79. Illumina, Inc. Recent Development Table 80. New England Biolabs Company Information Table 81. New England Biolabs Business Overview Table 82. New England Biolabs Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 83. New England Biolabs Ligases Enzymes Product Portfolio Table 84. New England Biolabs Recent Development Table 85. Promega Company Information Table 86. Promega Business Overview Table 87. Promega Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 88. Promega Ligases Enzymes Product Portfolio Table 89. Promega Recent Development Table 90. QIAGEN Company Information Table 91. QIAGEN Business Overview Table 92. QIAGEN Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 93. QIAGEN Ligases Enzymes Product Portfolio Table 94. QIAGEN Recent Development Table 95. Roche Company Information Table 96. Roche Business Overview Table 97. Roche Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 98. Roche Ligases Enzymes Product Portfolio Table 99. Roche Recent Development Table 100. Takara Company Information Table 101. Takara Business Overview Table 102. Takara Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 103. Takara Ligases Enzymes Product Portfolio Table 104. Takara Recent Development Table 105. Thermo Fisher Scientific Company Information Table 106. Thermo Fisher Scientific Business Overview Table 107. Thermo Fisher Scientific Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 108. Thermo Fisher Scientific Ligases Enzymes Product Portfolio Table 109. Thermo Fisher Scientific Recent Development Table 110. Abclonal Company Information Table 111. Abclonal Business Overview Table 112. Abclonal Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 113. Abclonal Ligases Enzymes Product Portfolio Table 114. Abclonal Recent Development Table 115. Fapon Biotech Inc Company Information Table 116. Fapon Biotech Inc Business Overview Table 117. Fapon Biotech Inc Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 118. Fapon Biotech Inc Ligases Enzymes Product Portfolio Table 119. Fapon Biotech Inc Recent Development Table 120. Novoprotein Company Information Table 121. Novoprotein Business Overview Table 122. Novoprotein Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 123. Novoprotein Ligases Enzymes Product Portfolio Table 124. Novoprotein Recent Development Table 125. CWbio Company Information Table 126. CWbio Business Overview Table 127. CWbio Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 128. CWbio Ligases Enzymes Product Portfolio Table 129. CWbio Recent Development Table 130. Vazyme Company Information Table 131. Vazyme Business Overview Table 132. Vazyme Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 133. Vazyme Ligases Enzymes Product Portfolio Table 134. Vazyme Recent Development Table 135. TransGen Biotech Company Information Table 136. TransGen Biotech Business Overview Table 137. TransGen Biotech Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 138. TransGen Biotech Ligases Enzymes Product Portfolio Table 139. TransGen Biotech Recent Development Table 140. Yeasen Company Information Table 141. Yeasen Business Overview Table 142. Yeasen Ligases Enzymes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 143. Yeasen Ligases Enzymes Product Portfolio Table 144. Yeasen Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Ligases Enzymes Distributors List Table 148. Ligases Enzymes Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Ligases Enzymes Product Image Figure 2. Global Ligases Enzymes Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ligases Enzymes Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ligases Enzymes Sales (2021-2032) & (kg) Figure 5. Global Ligases Enzymes Sales Average Price (USD/g) & (2021-2032) Figure 6. Global Ligases Enzymes Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. DNA Ligase Image Figure 10. RNA Ligase Image Figure 11. Global Ligases Enzymes Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Ligases Enzymes Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ligases Enzymes Sales Volume Share by Type (2021-2032) Figure 14. Global Ligases Enzymes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ligases Enzymes Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ligases Enzymes Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical & Biotechnology Companies Image Figure 18. Hospitals & Diagnostic Centers Image Figure 19. Academic & Research Institutes Image Figure 20. Others Image Figure 21. Global Ligases Enzymes Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Ligases Enzymes Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ligases Enzymes Sales Volume Share by Application (2021-2032) Figure 24. Global Ligases Enzymes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ligases Enzymes Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ligases Enzymes Sales Value Share by Application (2021-2032) Figure 27. Global Ligases Enzymes Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Ligases Enzymes Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ligases Enzymes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ligases Enzymes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ligases Enzymes Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ligases Enzymes Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ligases Enzymes Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ligases Enzymes Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ligases Enzymes Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ligases Enzymes Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ligases Enzymes Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ligases Enzymes Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ligases Enzymes Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ligases Enzymes Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ligases Enzymes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ligases Enzymes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ligases Enzymes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ligases Enzymes Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ligases Enzymes Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Ligase
  • RNA Ligase
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes
  • Others
Companies covered
  • Agilent
  • BioRad
  • Illumina, Inc.
  • New England Biolabs
  • Promega
  • QIAGEN
  • Roche
  • Takara
  • Thermo Fisher Scientific
  • Abclonal
  • Fapon Biotech Inc
  • Novoprotein
  • CWbio
  • Vazyme
  • TransGen Biotech
  • Yeasen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ligases Enzymes Sales Value (2021-2032)
  4. 1.2.2 Global Ligases Enzymes Sales Volume (2021-2032)
  5. 1.2.3 Global Ligases Enzymes Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ligases Enzymes Market Dynamics
  1. 2.1 Ligases Enzymes Industry Trends
  2. 2.2 Ligases Enzymes Industry Drivers
  3. 2.3 Ligases Enzymes Industry Opportunities and Challenges
  4. 2.4 Ligases Enzymes Industry Restraints
3 Ligases Enzymes Market by Company
  1. 3.1 Global Ligases Enzymes Company Revenue Ranking in 2025
  2. 3.2 Global Ligases Enzymes Revenue by Company (2021-2026)
  3. 3.3 Global Ligases Enzymes Sales Volume by Company (2021-2026)
  4. 3.4 Global Ligases Enzymes Average Price by Company (2021-2026)
  5. 3.5 Global Ligases Enzymes Company Ranking (2024-2026)
  6. 3.6 Global Ligases Enzymes Company Manufacturing Base and Headquarters
  7. 3.7 Global Ligases Enzymes Company Product Type and Application
  8. 3.8 Global Ligases Enzymes Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ligases Enzymes Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ligases Enzymes Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ligases Enzymes Market by Type
  1. 4.1 Ligases Enzymes Type Introduction
  2. 4.1.1 DNA Ligase
  3. 4.1.2 RNA Ligase
  4. 4.2 Global Ligases Enzymes Sales Volume by Type
  5. 4.2.1 Global Ligases Enzymes Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ligases Enzymes Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ligases Enzymes Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ligases Enzymes Sales Value by Type
  9. 4.3.1 Global Ligases Enzymes Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ligases Enzymes Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ligases Enzymes Sales Value Share by Type (2021-2032)
5 Ligases Enzymes Market by Application
  1. 5.1 Ligases Enzymes Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospitals & Diagnostic Centers
  4. 5.1.3 Academic & Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Ligases Enzymes Sales Volume by Application
  7. 5.2.1 Global Ligases Enzymes Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ligases Enzymes Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ligases Enzymes Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ligases Enzymes Sales Value by Application
  11. 5.3.1 Global Ligases Enzymes Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ligases Enzymes Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ligases Enzymes Sales Value Share by Application (2021-2032)
6 Ligases Enzymes Regional Sales and Value Analysis
  1. 6.1 Global Ligases Enzymes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ligases Enzymes Sales by Region (2021-2032)
  3. 6.2.1 Global Ligases Enzymes Sales by Region: 2021-2026
  4. 6.2.2 Global Ligases Enzymes Sales by Region (2027-2032)
  5. 6.3 Global Ligases Enzymes Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ligases Enzymes Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ligases Enzymes Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ligases Enzymes Sales Value by Region (2027-2032)
  9. 6.5 Global Ligases Enzymes Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ligases Enzymes Sales Value (2021-2032)
  12. 6.6.2 North America Ligases Enzymes Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ligases Enzymes Sales Value (2021-2032)
  15. 6.7.2 Europe Ligases Enzymes Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ligases Enzymes Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ligases Enzymes Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ligases Enzymes Sales Value (2021-2032)
  21. 6.9.2 South America Ligases Enzymes Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ligases Enzymes Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ligases Enzymes Sales Value Share by Country, 2025 VS 2032
7 Ligases Enzymes Country-level Sales and Value Analysis
  1. 7.1 Global Ligases Enzymes Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ligases Enzymes Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ligases Enzymes Sales by Country (2021-2032)
  4. 7.3.1 Global Ligases Enzymes Sales by Country (2021-2026)
  5. 7.3.2 Global Ligases Enzymes Sales by Country (2027-2032)
  6. 7.4 Global Ligases Enzymes Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ligases Enzymes Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ligases Enzymes Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ligases Enzymes Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ligases Enzymes Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ligases Enzymes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ligases Enzymes Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ligases Enzymes Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ligases Enzymes Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ligases Enzymes Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ligases Enzymes Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ligases Enzymes Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ligases Enzymes Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ligases Enzymes Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ligases Enzymes Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ligases Enzymes Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ligases Enzymes Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ligases Enzymes Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ligases Enzymes Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ligases Enzymes Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ligases Enzymes Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ligases Enzymes Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ligases Enzymes Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ligases Enzymes Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ligases Enzymes Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ligases Enzymes Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ligases Enzymes Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ligases Enzymes Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ligases Enzymes Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ligases Enzymes Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ligases Enzymes Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ligases Enzymes Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ligases Enzymes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent
  2. 8.1.1 Agilent Company Information
  3. 8.1.2 Agilent Business Overview
  4. 8.1.3 Agilent Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Ligases Enzymes Product Portfolio
  6. 8.1.5 Agilent Recent Developments
  7. 8.2 BioRad
  8. 8.2.1 BioRad Company Information
  9. 8.2.2 BioRad Business Overview
  10. 8.2.3 BioRad Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BioRad Ligases Enzymes Product Portfolio
  12. 8.2.5 BioRad Recent Developments
  13. 8.3 Illumina, Inc.
  14. 8.3.1 Illumina, Inc. Company Information
  15. 8.3.2 Illumina, Inc. Business Overview
  16. 8.3.3 Illumina, Inc. Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Illumina, Inc. Ligases Enzymes Product Portfolio
  18. 8.3.5 Illumina, Inc. Recent Developments
  19. 8.4 New England Biolabs
  20. 8.4.1 New England Biolabs Company Information
  21. 8.4.2 New England Biolabs Business Overview
  22. 8.4.3 New England Biolabs Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 New England Biolabs Ligases Enzymes Product Portfolio
  24. 8.4.5 New England Biolabs Recent Developments
  25. 8.5 Promega
  26. 8.5.1 Promega Company Information
  27. 8.5.2 Promega Business Overview
  28. 8.5.3 Promega Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Promega Ligases Enzymes Product Portfolio
  30. 8.5.5 Promega Recent Developments
  31. 8.6 QIAGEN
  32. 8.6.1 QIAGEN Company Information
  33. 8.6.2 QIAGEN Business Overview
  34. 8.6.3 QIAGEN Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 QIAGEN Ligases Enzymes Product Portfolio
  36. 8.6.5 QIAGEN Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Roche Ligases Enzymes Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Takara
  44. 8.8.1 Takara Company Information
  45. 8.8.2 Takara Business Overview
  46. 8.8.3 Takara Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Takara Ligases Enzymes Product Portfolio
  48. 8.8.5 Takara Recent Developments
  49. 8.9 Thermo Fisher Scientific
  50. 8.9.1 Thermo Fisher Scientific Company Information
  51. 8.9.2 Thermo Fisher Scientific Business Overview
  52. 8.9.3 Thermo Fisher Scientific Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Thermo Fisher Scientific Ligases Enzymes Product Portfolio
  54. 8.9.5 Thermo Fisher Scientific Recent Developments
  55. 8.10 Abclonal
  56. 8.10.1 Abclonal Company Information
  57. 8.10.2 Abclonal Business Overview
  58. 8.10.3 Abclonal Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Abclonal Ligases Enzymes Product Portfolio
  60. 8.10.5 Abclonal Recent Developments
  61. 8.11 Fapon Biotech Inc
  62. 8.11.1 Fapon Biotech Inc Company Information
  63. 8.11.2 Fapon Biotech Inc Business Overview
  64. 8.11.3 Fapon Biotech Inc Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fapon Biotech Inc Ligases Enzymes Product Portfolio
  66. 8.11.5 Fapon Biotech Inc Recent Developments
  67. 8.12 Novoprotein
  68. 8.12.1 Novoprotein Company Information
  69. 8.12.2 Novoprotein Business Overview
  70. 8.12.3 Novoprotein Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Novoprotein Ligases Enzymes Product Portfolio
  72. 8.12.5 Novoprotein Recent Developments
  73. 8.13 CWbio
  74. 8.13.1 CWbio Company Information
  75. 8.13.2 CWbio Business Overview
  76. 8.13.3 CWbio Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CWbio Ligases Enzymes Product Portfolio
  78. 8.13.5 CWbio Recent Developments
  79. 8.14 Vazyme
  80. 8.14.1 Vazyme Company Information
  81. 8.14.2 Vazyme Business Overview
  82. 8.14.3 Vazyme Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Vazyme Ligases Enzymes Product Portfolio
  84. 8.14.5 Vazyme Recent Developments
  85. 8.15 TransGen Biotech
  86. 8.15.1 TransGen Biotech Company Information
  87. 8.15.2 TransGen Biotech Business Overview
  88. 8.15.3 TransGen Biotech Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 TransGen Biotech Ligases Enzymes Product Portfolio
  90. 8.15.5 TransGen Biotech Recent Developments
  91. 8.16 Yeasen
  92. 8.16.1 Yeasen Company Information
  93. 8.16.2 Yeasen Business Overview
  94. 8.16.3 Yeasen Ligases Enzymes Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Yeasen Ligases Enzymes Product Portfolio
  96. 8.16.5 Yeasen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ligases Enzymes Value Chain Analysis
  2. 9.1.1 Ligases Enzymes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ligases Enzymes Sales Mode & Process
  6. 9.2 Ligases Enzymes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ligases Enzymes Distributors
  9. 9.2.3 Ligases Enzymes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst